Skip to main content

Losartan Potassium Tablets

Posting Date: 30–Jun–2011

Official Date: 01–Jul–2011

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Losartan Potassium Tablets monograph. The purpose for the revision is to add Dissolution Test 2 for a new generic product.

The Losartan Potassium Tablets Revision Bulletin supersedes the currently official Losartan Potassium Tablets monograph. The Revision Bulletin will be incorporated in USP 35–NF 30.

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., M.B.A. (301-816-8349 or sxr@usp.org).